Evolution of the Average Target: Bekaert NV

Evolution of the Target Price: Bekaert NV

Changes in Analyst Recommendations: Bekaert NV

f772261ca72d7864670a36e02f5c.W9BtZHVRPRFe36kYXVbXxVKcX0ACCMkp1gITDXankmU.KoQdABAnfF1v6fpwbzCiqz7vbRl7W4xFk2FpSxH04ScftBk2GGducw7pmQ~5a9ac1b9a70926e08e2e456e843505a8
07-31 Bekaert: 1H26: BBRG is in trouble Alphavalue
07-07 Bekaert: EPS cut (2026: -10.0%, 2027: -8.4%) Alphavalue
05-20 Bekaert: 1Q26: Benefiting from electrification trends in the US Alphavalue
04-13 Bekaert: EPS cut (2025: -68.1%, 2026: -8.4%) Alphavalue
02-26 Bekaert: FY2025: Resilient results Alphavalue
01-19 Bekaert lowers 2025 EPS on restructuring costs Alphavalue
11-26 AlphaValue/Baader Europe Cuts Earnings Estimates for Bekaert Post Q3 Update MT
11-25 Bekaert trimmed EPS outlook and lower capex support attractive valuation Alphavalue
11-24 Bekaert shows resilient Q3 2025 performance despite weaker demand Alphavalue
31/07/25 Bekaert: Uncertainty pressures sales; cost controls support margin resilience Alphavalue
22/05/25 Correction: AlphaValue/Baader Europe Adjusts Bekaert Estimates MT
21/05/25 Bekaert: EPS cut (2024: -3.0%, 2025: -6.3%) Alphavalue
14/05/25 Bekaert: Solid Q1 performance in line with expectations amid tariff uncertainty Alphavalue
17/03/25 Bekaert: Lower volumes weigh on FY24, FY25 outlook remains challenging Alphavalue
09/01/25 Bekaert: EPS cut (2024: -6.8%, 2025: -1.5%) Alphavalue
04/12/24 Bekaert: Challenging Q3 hit by lower volumes and adverse impact from raw-material costs Alphavalue
24/09/24 Bekaert: Opinion change, from Buy to Reduce Alphavalue
12/08/24 Bekaert: Mixed H1 results: Strong SWS performance, growth segments under pressure Alphavalue
22/05/24 Q1 2024: Some misses, some beats, a few surprises and broadly lofty valuations Alphavalue
11/12/23 Bekaert : CMD takeway: legacy divisions to drive the significance of the growth divisions Alphavalue
20/11/23 Bekaert : Q3 23: volumes have yet to land Alphavalue
02/03/23 Bekaert : Closing FY22 on a strong FCF, 8.8% yield, and acceleration in hydrogen Alphavalue
18/11/22 Bekaert : Q3 22: huge pricing and lower volumes again; a FY22 guidance, at last Alphavalue
16/05/22 Bekaert : Q1 22 figures showed astonishing pricing and weakening volumes Alphavalue
03/03/22 Bekaert : Expectation-beating FY21 results, strong set-up to navigate the crisis Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+15.33%
+5.3%
+18.61%
+6.6%
+1.13%
- - +19.55%
+0.71%
+12.93%
+5.65%
Average +9.54%
Weighted average by Cap. +8.89%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
38.15EUR
Average target price
44.00EUR
Spread / Average Target
+15.33%
High Price Target
55.00EUR
Spread / Highest target
+44.17%
Low Price Target
34.50EUR
Spread / Lowest Target
-9.57%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
A
  1. Stock Market
  2. Stocks
  3. BEKB Stock
  4. Consensus Bekaert NV
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!